Study provides new look at why rare cancer often evades treatments

Por um escritor misterioso

Descrição

Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Study provides new look at why rare cancer often evades treatments
Count Me In launches a rare cancer research project to engage leiomyosarcoma patients and families
Study provides new look at why rare cancer often evades treatments
Study provides new look at why rare cancer often evades treatments
Study provides new look at why rare cancer often evades treatments
A research team searches for every gene that helps tumors evade immunotherapy
Study provides new look at why rare cancer often evades treatments
Cancers, Free Full-Text
Study provides new look at why rare cancer often evades treatments
CAR T-cell therapy turns blood into a cancer-fighting weapon
Study provides new look at why rare cancer often evades treatments
New look at why rare cancer often evades treatments - ecancer
Study provides new look at why rare cancer often evades treatments
The Possibilities and Risks of Genetically Altering Immune Cells to Fight Cancer, Science
Study provides new look at why rare cancer often evades treatments
Investigating the Abscopal Effect as a Treatment for Cancer - NCI
Study provides new look at why rare cancer often evades treatments
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies - ScienceDirect
Study provides new look at why rare cancer often evades treatments
Discovering targets and biomarkers for immunotherapies - Genevia Technologies
Study provides new look at why rare cancer often evades treatments
Cancers, Free Full-Text
Study provides new look at why rare cancer often evades treatments
Resistant cancer cells can be targeted for elimination — Harvard Gazette
Study provides new look at why rare cancer often evades treatments
Liquid Biopsy' Blood Test for Cancer Cells Boosted
Study provides new look at why rare cancer often evades treatments
The future of early cancer detection
de por adulto (o preço varia de acordo com o tamanho do grupo)